Lexeo Therapeutics, Inc. Common Stock Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
JANUS HENDERSON GROUP PLC | 02/14/2025 | 4.34 M | $28.51 M | 15.31% | 13.12% |
CITADEL ADVISORS LLC | 02/14/2025 | 2.72 M | $17.92 M | 0.00% | 8.24% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 02/14/2025 | 2.21 M | $14.54 M | -14.94% | 6.68% |
D1 CAPITAL PARTNERS L.P. | 02/14/2025 | 2.20 M | $14.50 M | -12.08% | 6.67% |
BLACKROCK, INC. | 02/07/2025 | 1.82 M | $11.99 M | 11.76% | 5.51% |
EVENTIDE ASSET MANAGEMENT, LLC | 02/14/2025 | 1.23 M | $8.13 M | -33.47% | 3.73% |
VESTAL POINT CAPITAL, LP | 02/14/2025 | 1.20 M | $7.90 M | 41.18% | 3.63% |
OMEGA FUND MANAGEMENT, LLC | 02/14/2025 | 1.18 M | $7.79 M | -49.72% | 3.58% |
BLACKSTONE INC. | 02/14/2025 | 1.16 M | $7.62 M | 0.00% | 3.50% |
NOVO HOLDINGS A/S | 02/14/2025 | 1.12 M | $7.39 M | 0.00% | 3.40% |
FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 02/18/2025 | 955,515 | $6.29 M | -23.61% | 2.89% |
WOODLINE PARTNERS LP | 02/14/2025 | 858,691 | $5.65 M | 0.79% | 2.60% |
POINT72 ASSET MANAGEMENT, L.P. | 02/14/2025 | 750,235 | $4.94 M | 102.54% | 2.27% |
VERITION FUND MANAGEMENT LLC | 02/14/2025 | 709,900 | $4.67 M | -8.67% | 2.15% |
SIREN, L.L.C. | 02/14/2025 | 603,435 | $3.97 M | 0.00% | 1.83% |
GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 567,383 | $3.73 M | 2.56% | 1.72% |
RA CAPITAL MANAGEMENT, L.P. | 02/14/2025 | 546,554 | $3.60 M | 0.00% | 1.65% |
IKARIAN CAPITAL, LLC | 02/14/2025 | 499,301 | $3.29 M | 94.12% | 1.51% |
ALTIUM CAPITAL MANAGEMENT LP | 02/13/2025 | 405,000 | $2.66 M | 100.00% | 1.22% |
DAFNA CAPITAL MANAGEMENT LLC | 02/14/2025 | 393,083 | $2.59 M | 56.87% | 1.19% |
LAURION CAPITAL MANAGEMENT LP | 02/14/2025 | 260,228 | $1.71 M | 0.00% | 0.79% |
NORTHERN TRUST CORP | 02/14/2025 | 214,284 | $1.41 M | 7.09% | 0.65% |
ADAR1 CAPITAL MANAGEMENT, LLC | 02/13/2025 | 169,505 | $1.12 M | 196.51% | 0.51% |
BOOTHBAY FUND MANAGEMENT, LLC | 02/14/2025 | 147,807 | $972,570 | 37.52% | 0.45% |
MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 141,951 | $934,038 | 282.47% | 0.43% |
PERCEPTIVE ADVISORS LLC | 02/14/2025 | 139,835 | $920,114 | 0.00% | 0.42% |
PRIVIUM FUND MANAGEMENT B.V. | 02/11/2025 | 138,115 | $908,797 | 100.00% | 0.42% |
OPALEYE MANAGEMENT INC. | 02/14/2025 | 130,000 | $855,400 | 100.00% | 0.39% |
WELLINGTON MANAGEMENT GROUP LLP | 02/12/2025 | 76,981 | $506,535 | 48.35% | 0.23% |
MORGAN STANLEY | 02/14/2025 | 74,828 | $492,368 | -69.06% | 0.23% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 02/14/2025 | 65,000 | $427,700 | 100.00% | 0.20% |
WALLEYE CAPITAL LLC | 02/13/2025 | 61,930 | $407,499 | 100.00% | 0.19% |
SUPERSTRING CAPITAL MANAGEMENT LP | 02/14/2025 | 52,616 | $346,213 | 100.00% | 0.16% |
NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 36,050 | $237,209 | 0.00% | 0.11% |
BANK OF AMERICA CORP /DE/ | 02/14/2025 | 30,376 | $199,873 | -21.68% | 0.09% |
ARISTIDES CAPITAL LLC | 02/13/2025 | 29,285 | $192,695 | 100.00% | 0.09% |
RHUMBLINE ADVISERS | 01/30/2025 | 25,197 | $165,788 | 19.59% | 0.08% |
CITIGROUP INC | 02/12/2025 | 24,924 | $164,000 | 7.87% | 0.08% |
JUMP FINANCIAL, LLC | 02/13/2025 | 20,400 | $134,232 | 100.00% | 0.06% |
CAXTON CORP | 02/14/2025 | 17,851 | $117,460 | 0.00% | 0.05% |
MARSHALL WACE, LLP | 02/13/2025 | 17,794 | $117,084 | 100.00% | 0.05% |
PALE FIRE CAPITAL SE | 02/13/2025 | 16,100 | $105,938 | 100.00% | 0.05% |
ALLIANCEBERNSTEIN L.P. | 02/12/2025 | 15,970 | $105,083 | 0.00% | 0.05% |
CORTON CAPITAL INC. | 02/14/2025 | 13,771 | $90,613 | 100.00% | 0.04% |
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 02/14/2025 | 13,477 | $88,679 | 4.72% | 0.04% |
COREBRIDGE FINANCIAL, INC. | 02/11/2025 | 11,715 | $77,085 | -7.02% | 0.04% |
INTECH INVESTMENT MANAGEMENT LLC | 02/11/2025 | 11,565 | $76,098 | 100.00% | 0.04% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 11,148 | $73,354 | 100.00% | 0.03% |
CHINA UNIVERSAL ASSET MANAGEMENT CO., LTD. | 01/24/2025 | 7,011 | $46,132 | 100.00% | 0.02% |
02/11/2025 | 6,040 | $39,743 | 100.00% | 0.02% |
Lexeo Therapeutics, Inc. Common Stock institutional Ownership - FAQ's
During the previous two years, 71 institutional investors and hedge funds held shares of Lexeo Therapeutics, Inc. Common Stock. The most heavily invested institutionals were:
ROTHSCHILD INVESTMENT LLC: 0
GAMMA Investing LLC: 0
JANUS HENDERSON GROUP PLC: 4.34 M
CITADEL ADVISORS LLC: 2.72 M
ADAGE CAPITAL PARTNERS GP, L.L.C.: 2.21 M
D1 Capital Partners L.P.: 2.2 M
87.86% of Lexeo Therapeutics, Inc. Common Stock stock is owned by institutional investors.
Institutional investors have bought a total of 28.27 M shares in the last 24 months. This purchase volume represents approximately $64.45 M in transactions.